Evidence map›Paper›PMID 41301144›Full record

ArticleBioengineering (Basel, Switzerland)2025

Enhanced Blood Cell Detection in YOLOv11n Using Gradient Accumulation and Loss Reweighting.

Min Feng, Juncai Xu

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Min FengThe Affiliated Brain Hospital, Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0003-1193-8259
Juncai XuSchool of Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0001-9341-5077

Funding

Nanjing Municipal Health Science and Technology Development Project YKK24191
6 · The paper itself

Abstract

Automated blood cell detection is of significant importance in the efficient and accurate diagnosis of hematological diseases. The application of this technology has advanced clinical practice in hematology and improved the speed and accuracy of diagnosis, thereby providing patients with more timely medical intervention. In this study, the YOLOv11n model was optimized by integrating gradient accumulation and loss reweighting techniques to improve its detection performance for blood cells in clinical images. The optimized YOLOv11n model shows an improvement in performance. The mAP50 reached 0.9356, the mAP50-95 was 0.6620, and the precision and recall were better than those of existing methods. The model can effectively address issues such as dense cell distribution, cell overlap, and image artifacts. Therefore, it is highly applicable in real-time clinical applications. The results of the ablation experiment demonstrate that there is a synergistic effect between gradient accumulation and loss reweighting, which can improve detection accuracy without increasing the computational burden. The conclusion indicates that the optimized YOLOv11n model has important application prospects as an automated blood cell detection tool and has the potential to integrate with clinical workflows.

Indexed as

blood cell detectiongradient accumulationloss reweightingYOLO

Identifiers

PMID41301144
PMCPMC12649632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.